Close

Neurotrack - Transforming the diagnosis & treatment of Alzheimer’s

Posted on by Brandon Klein

Transforming the diagnosis & treatment of Alzheimer’s

Neurotrack's technology can diagnose the onset of Alzheimer’s Disease three to four years before symptoms occur. Based on ground-breaking research, it enables pharmaceutical companies and researchers to recruit qualified candidates for clinical trials, and more effectively measure drug efficacy, speeding up drug discovery and development.

Neurotrack is also becoming the standard for early clinical screening of Alzheimer’s and dementia related disorders.